• Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue

FDA approves nasal glucagon, Baqsimi

06/09/2019 No Comments

The U.S. Food and Drug Administration (FDA) has approved Baqsimi (glucagon) nasal powder 3mg for the treatment of severe hypoglycemia in people with diabetes ages

Read More ยป

Follow us elsewhere

Facebook Twitter Instagram

Latest tweets

Twitter: desangsue
Sue Marshall
  • Weather warning to people living with diabetes from Diabetes UK - https://t.co/BxFbhfqMQm 06:17:09 PM July 14, 2022
@desangsue

Recent posts

ADA supports INSULIN Act to reduce costs

Australians with T1D to get subsidised CGM devices

IDDT get together in October

  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Site by Loopmill